Bank Of Montreal Catalent, Inc. Transaction History

Bank Of Montreal

$201 Billion
Q2 2025

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$56.16 - $60.96 $65.7 Million - $71.3 Million	1,169,044 Added 181.49%	1,813,167 $110 Million
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $23.8 Million - $25.3 Million	444,084 Added 222.0%	644,123 $36.2 Million
Q1 2024 May 13, 2024	SELL	$42.56 - $59.82 $2.31 Million - $3.24 Million	-54,213 Reduced 21.32%	200,039 $11.3 Million
Q4 2023 Feb 08, 2024	BUY	$32.18 - $46.57 $1.14 Million - $1.66 Million	35,571 Added 16.27%	254,252 $11.4 Million
Q3 2023 Nov 01, 2023	SELL	$44.2 - $50.2 $1.68 Million - $1.9 Million	-37,903 Reduced 14.77%	218,681 $9.96 Million
Q2 2023 Aug 02, 2023	BUY	$31.86 - $67.26 $2.52 Million - $5.31 Million	78,947 Added 44.44%	256,584 $11.1 Million
Q1 2023 Jun 13, 2024	SELL	$45.44 - $74.26 $414,003 - $676,582	-9,111 Reduced 4.55%	190,928 $12.5 Million
Q4 2022 Feb 01, 2023	BUY	$41.39 - $81.0 $385,920 - $755,244	9,324 Added 5.54%	177,637 $7.99 Million
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $2.86 Million - $4.47 Million	-39,520 Reduced 19.02%	168,313 $12.6 Million
Q2 2022 Aug 11, 2022	BUY	$87.2 - $114.05 $4.66 Million - $6.09 Million	53,417 Added 34.59%	207,833 $23.1 Million
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $1.54 Million - $2.04 Million	-16,361 Reduced 9.58%	154,416 $17.1 Million
Q4 2021 Feb 11, 2022	SELL	$119.57 - $139.07 $34.7 Million - $40.4 Million	-290,194 Reduced 62.95%	170,777 $22 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $2.66 Million - $3.47 Million	-24,375 Reduced 5.02%	460,971 $62.1 Million
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $48.7 Million - $56.1 Million	485,346 New	485,346 $53.4 Million

Others Institutions Holding CTLT

# of Institutions

Shares Held

16.5M

Call Options Held

10.7K

Put Options Held

4.5K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account